{"name":"SEBELA IRELAND LTD","slug":"sebela-ireland-ltd","ticker":"","exchange":"","domain":"sebelaireland.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1978-01-01","label":"Motofen first approved","drug":"Motofen","drugSlug":"difenoxin","type":"approval","sentiment":"positive"},{"date":"1992-01-01","label":"Sporanox first approved","drug":"Sporanox","drugSlug":"itraconazole","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2033-06-21","label":"Sporanox patent expiry (Formulation)","drug":"Sporanox","drugSlug":"itraconazole","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-21","label":"Sporanox patent expiry (Method of Use)","drug":"Sporanox","drugSlug":"itraconazole","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-21","label":"Sporanox patent expiry (Formulation)","drug":"Sporanox","drugSlug":"itraconazole","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-21","label":"Sporanox patent expiry (Formulation)","drug":"Sporanox","drugSlug":"itraconazole","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-21","label":"Sporanox patent expiry (Formulation)","drug":"Sporanox","drugSlug":"itraconazole","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Sporanox","genericName":"itraconazole","slug":"itraconazole","indication":"Aspergillosis","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Motofen","genericName":"DIFENOXIN","slug":"difenoxin","indication":"Diarrhea","status":"marketed"}]}],"pipeline":[{"name":"Sporanox","genericName":"itraconazole","slug":"itraconazole","phase":"marketed","mechanism":"C-X-C chemokine receptor type 1","indications":["Aspergillosis","Blastomycosis","Candidemia","Candidiasis of the esophagus","Disseminated candidiasis"],"catalyst":""},{"name":"Motofen","genericName":"DIFENOXIN","slug":"difenoxin","phase":"marketed","mechanism":"Mu-type opioid receptor","indications":["Diarrhea"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[{"drugName":"Sporanox","drugSlug":"itraconazole","patentNumber":"10463740","type":"Formulation","expiryDate":"2033-06-21","territory":"US","genericFilings":[]},{"drugName":"Sporanox","drugSlug":"itraconazole","patentNumber":"9713642","type":"Method of Use","expiryDate":"2033-06-21","territory":"US","genericFilings":[]},{"drugName":"Sporanox","drugSlug":"itraconazole","patentNumber":"10806792","type":"Formulation","expiryDate":"2033-06-21","territory":"US","genericFilings":[]},{"drugName":"Sporanox","drugSlug":"itraconazole","patentNumber":"8921374","type":"Formulation","expiryDate":"2033-06-21","territory":"US","genericFilings":[]},{"drugName":"Sporanox","drugSlug":"itraconazole","patentNumber":"9272046","type":"Formulation","expiryDate":"2033-06-21","territory":"US","genericFilings":[]}],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}